Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

scientific article published in December 1995

Increased serum interleukin-1-receptor-antagonist concentrations in major depression. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0165-0327(95)00049-6
P698PubMed publication ID8988262

P50authorMichael MaesQ30504745
P2093author name stringR Ranjan
E Bosmans
R Desnyder
E Vandoolaeghe
R Bergmans
P433issue1-2
P304page(s)29-36
P577publication date1995-12-01
P1433published inJournal of Affective DisordersQ15716493
P1476titleIncreased serum interleukin-1-receptor-antagonist concentrations in major depression.
P478volume36

Reverse relations

cites work (P2860)
Q27303855A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice
Q56767386Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs
Q36128113Association between Serum Ferritin Concentrations and Depressive Symptoms among Chinese Adults: A Population Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study
Q34348095Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans
Q48379121Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study
Q37459522Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.
Q48149717Behavioral changes in rats after acute, chronic and repeated administration of interleukin-1beta: relevance for affective disorders
Q37529769Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment.
Q36175060Cellular and Molecular Inflammatory Profile of the Choroid Plexus in Depression and Suicide
Q37225947Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications
Q35755435Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways
Q26752379Depression and the Link with Cardiovascular Disease
Q41705538Depression, stress and immunological activation: the role of cytokines in depressive disorders
Q42052097Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events
Q92714877Evaluation on monoamine neurotransmitters changes in depression rats given with sertraline, meloxicam or/and caffeic acid
Q48031471High serum levels of leptin are associated with post-stroke depression.
Q47646440Hope for a Better World
Q28396103Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience
Q80508135Immune parameters in patients with anxiety or depression during psychotherapy
Q35233681Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis.
Q48426795Inflammatory cytokines, socioeconomic status, and acute stress responsivity
Q47657388Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study
Q51090174Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes.
Q73331958Interleukin-1 beta production in dysthymia before and after pharmacotherapy
Q37193601Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study
Q42458336Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia
Q49010960Is exogenous administration of IL-1ra (anakinra) likely to induce severe depression?
Q47719124Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia
Q93103635Modulation of the neurotransmitter systems through the anti-inflammatory and antidepressant-like effects of squalene from Aurantiochytrium sp
Q36896665Neuro-oncology family caregivers are at risk for systemic inflammation
Q33872507Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression
Q36901407Pharmacogenomics of neuroimmune interactions in human psychiatric disorders
Q51981236Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.
Q35554351Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder
Q36134214Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis
Q35189666Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment
Q37562443Sirukumab: A Potential Treatment for Mood Disorders?
Q38038284Targeting IL-1 in depression
Q56767037The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder
Q52317553The effect of trauma and alcohol on the relationship between level of cytokines and depression among patients entering psychiatric treatment.
Q36559288The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines.
Q28141553The in vitro immunosuppressive effects of moclobemide in healthy volunteers
Q47965029The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression
Q37956964The influence of depression on the progression of HIV: direct and indirect effects
Q38067080The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review
Q37152050Vascular factors and depression
Q47137050Visceral Inflammation and Immune Activation Stress the Brain

Search more.